Prevention of type 2 diabetes mellitus from the viewpoint of genetics

Diabetes Research and Clinical Practice

Volumn 66, Issue SUPPL., 2004, Pages

  Park, Kyong Soo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Gene to environmental interaction; Prevention; Susceptibility genes; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TETRAHYDROLIPSTATIN; TROGLITAZONE;

CELL FUNCTION; CLINICAL TRIAL; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DIABETOGENESIS; DIET RESTRICTION; DISEASE PREDISPOSITION; ECONOMIC ASPECT; EXERCISE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PREVALENCE; RISK ASSESSMENT; RISK REDUCTION;

DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; INSULIN RESISTANCE;

EID: 9644310315     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.11.023     Document Type: Conference Paper

References (15)

1. Amos A.F., McCarty D.J., Zimmet P P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med. 14(Suppl. 5):1997;S1-S85
2. Massi-Benedetti M. CODE-2 advisory board: the cost of diabetes type II in Europe: the CODE-2 study. Diabetologia. 45:2002;S1-S4
3. Prevention of diabetes mellitus, Report of a WHO Study Group, WHO Technical Report Series, No. 844, Geneva World Health Organization, 1994.
4. Tuomilehto J., Lindstrom J., Eriksson J.G., et al. Finnish diabetes prevention study group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344:2001;1343-1350
5. Knowler W.C., Barrett-Connor E., Fowler S.E., et al. Diabetes prevention program research group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346:2002;393-403
6. Buchanan T.A., Xiang A.H., Peters R.K. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. 51:2002;2796-2803
7. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M. STOP-NIDDM trail research group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial. Lancet. 359:2002;2072-2077
8. Elbein S.C. Perspective: the search for genes for type 2 diabetes in the post-genome era. Endocrinology. 143:2002;2012-2018
9. Moore J.H., Williams S.M. New strategies for identifying gene-gene interactions in hypertension. Ann. Med. 34:2002;88-95
10. Ritchie M.D., Hahn L.W., Roodi N., et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am. J. Hum. Genet. 69:2001;138-147
11. Ritchie M.D., Hahn L.W., Moore J.H. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet. Epidemiol. 24:2003;150-157
12. Wareham N.J., Franks P.W., Harding A.H. Establishing the role of gene-environment interactions in the etiology of type 2 diabetes. Endocrinol. Metab. Clin. North Am. 31:2002;553-566
13. Altshuler D., Hirschhorn J.N., Klannemark M., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26:2000;76-80
14. Luan J., Browne P.O., Harding A.H. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes. 50:2001;686-689
15. Nemoto M., Sasaki T., Deeb S.S., Fujimoto W.Y., Tajima N. Differential effect of PPARgamma2 variants in the development of type 2 diabetes between native Japanese and Japanese Americans. Diabetes Res. Clin. Pract. 57:2002;131-137